US Stock MarketDetailed Quotes

IMNM Immunome

Watchlist
  • 14.620
  • 0.0000.00%
Close May 29 16:00 ET
  • 14.620
  • 0.0000.00%
Post 16:01 ET
876.74MMarket Cap-1938P/E (TTM)

Immunome Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-56.47%1.03M
14.02M
3.83M
3.57M
4.26M
2.36M
0
0
0
0
Operating revenue
-56.47%1.03M
--14.02M
--3.83M
--3.57M
--4.26M
--2.36M
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
212.71%21.37M
15.84%42.75M
127.01%17.68M
-3.94%8.2M
12.44%10.04M
-41.35%6.84M
46.41%36.9M
-0.73%7.79M
10.50%8.53M
55.51%8.93M
Selling and administrative expenses
105.51%6.01M
44.23%19.66M
127.44%8.04M
32.22%4.38M
34.62%4.32M
-18.29%2.92M
22.85%13.63M
2.20%3.54M
3.08%3.31M
28.00%3.21M
-General and administrative expense
105.51%6.01M
44.23%19.66M
127.44%8.04M
32.22%4.38M
34.62%4.32M
-18.29%2.92M
22.85%13.63M
2.20%3.54M
3.08%3.31M
28.00%3.21M
Research and development costs
292.77%15.37M
-0.79%23.09M
126.65%9.64M
-26.83%3.82M
-0.02%5.72M
-51.56%3.91M
64.93%23.27M
-3.03%4.25M
15.78%5.23M
76.83%5.72M
Operating profit
-355.04%-20.35M
22.15%-28.73M
-77.87%-13.85M
45.71%-4.63M
35.32%-5.77M
61.64%-4.47M
-46.41%-36.9M
0.73%-7.79M
-10.50%-8.53M
-55.51%-8.93M
Net non-operating interest income expense
1,296.52%2.81M
54,380.00%2.72M
201,800.00%2.02M
28,700.00%288K
10,700.00%216K
20,000.00%201K
150.00%5K
120.00%1K
133.33%1K
300.00%2K
Non-operating interest income
1,296.52%2.81M
54,380.00%2.72M
201,800.00%2.02M
28,700.00%288K
10,700.00%216K
20,000.00%201K
--5K
--1K
--1K
--2K
Other net income (expense)
-111.95M
-80.8M
Special income (charges)
---111.95M
---80.8M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
--111.95M
--80.8M
----
----
----
----
----
----
----
----
Income before tax
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
-10.53%-8.53M
-70.27%-8.92M
Income tax
Net income
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
-10.53%-8.53M
-70.27%-8.92M
Net income continuous Operations
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
-10.53%-8.53M
-70.27%-8.92M
Minority interest income
Net income attributable to the parent company
-2,932.60%-129.49M
-189.48%-106.81M
-1,089.75%-92.63M
49.08%-4.35M
37.73%-5.56M
63.36%-4.27M
-49.31%-36.9M
0.84%-7.79M
-10.53%-8.53M
-70.27%-8.92M
Preferred stock dividends
Other preferred stock dividends
0
0
0
622K
0
622K
Net income attributable to common stockholders
-2,932.60%-129.49M
-184.68%-106.81M
-1,089.75%-92.63M
52.54%-4.35M
37.73%-5.56M
63.36%-4.27M
-51.83%-37.52M
0.84%-7.79M
-18.59%-9.16M
-70.27%-8.92M
Basic earnings per share
-3,485.71%-12.55
-74.11%-5.38
-234.65%-2.1417
52.00%-0.36
37.84%-0.46
63.54%-0.35
-44.39%-3.09
1.54%-0.64
-15.38%-0.75
-60.87%-0.74
Diluted earnings per share
-3,485.71%-12.55
-74.11%-5.38
-234.65%-2.1417
52.00%-0.36
37.84%-0.46
63.54%-0.35
-44.39%-3.09
1.54%-0.64
-15.38%-0.75
-60.87%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -56.47%1.03M14.02M3.83M3.57M4.26M2.36M0000
Operating revenue -56.47%1.03M--14.02M--3.83M--3.57M--4.26M--2.36M--0--0--0--0
Cost of revenue
Gross profit
Operating expense 212.71%21.37M15.84%42.75M127.01%17.68M-3.94%8.2M12.44%10.04M-41.35%6.84M46.41%36.9M-0.73%7.79M10.50%8.53M55.51%8.93M
Selling and administrative expenses 105.51%6.01M44.23%19.66M127.44%8.04M32.22%4.38M34.62%4.32M-18.29%2.92M22.85%13.63M2.20%3.54M3.08%3.31M28.00%3.21M
-General and administrative expense 105.51%6.01M44.23%19.66M127.44%8.04M32.22%4.38M34.62%4.32M-18.29%2.92M22.85%13.63M2.20%3.54M3.08%3.31M28.00%3.21M
Research and development costs 292.77%15.37M-0.79%23.09M126.65%9.64M-26.83%3.82M-0.02%5.72M-51.56%3.91M64.93%23.27M-3.03%4.25M15.78%5.23M76.83%5.72M
Operating profit -355.04%-20.35M22.15%-28.73M-77.87%-13.85M45.71%-4.63M35.32%-5.77M61.64%-4.47M-46.41%-36.9M0.73%-7.79M-10.50%-8.53M-55.51%-8.93M
Net non-operating interest income expense 1,296.52%2.81M54,380.00%2.72M201,800.00%2.02M28,700.00%288K10,700.00%216K20,000.00%201K150.00%5K120.00%1K133.33%1K300.00%2K
Non-operating interest income 1,296.52%2.81M54,380.00%2.72M201,800.00%2.02M28,700.00%288K10,700.00%216K20,000.00%201K--5K--1K--1K--2K
Other net income (expense) -111.95M-80.8M
Special income (charges) ---111.95M---80.8M--------------0--0------------
-Less:Other special charges --111.95M--80.8M--------------------------------
Income before tax -2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M-10.53%-8.53M-70.27%-8.92M
Income tax
Net income -2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M-10.53%-8.53M-70.27%-8.92M
Net income continuous Operations -2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M-10.53%-8.53M-70.27%-8.92M
Minority interest income
Net income attributable to the parent company -2,932.60%-129.49M-189.48%-106.81M-1,089.75%-92.63M49.08%-4.35M37.73%-5.56M63.36%-4.27M-49.31%-36.9M0.84%-7.79M-10.53%-8.53M-70.27%-8.92M
Preferred stock dividends
Other preferred stock dividends 000622K0622K
Net income attributable to common stockholders -2,932.60%-129.49M-184.68%-106.81M-1,089.75%-92.63M52.54%-4.35M37.73%-5.56M63.36%-4.27M-51.83%-37.52M0.84%-7.79M-18.59%-9.16M-70.27%-8.92M
Basic earnings per share -3,485.71%-12.55-74.11%-5.38-234.65%-2.141752.00%-0.3637.84%-0.4663.54%-0.35-44.39%-3.091.54%-0.64-15.38%-0.75-60.87%-0.74
Diluted earnings per share -3,485.71%-12.55-74.11%-5.38-234.65%-2.141752.00%-0.3637.84%-0.4663.54%-0.35-44.39%-3.091.54%-0.64-15.38%-0.75-60.87%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg